Alary Jacques, Guéraud Françoise, Cravedi Jean-Pierre
Institut National de la Recherche Agronomique, UMR-1089 Xénobiotiques, BP 3, 180 chemin de Tournefeuille, 31931 Toulouse cedex 9, France.
Mol Aspects Med. 2003 Aug-Oct;24(4-5):177-87. doi: 10.1016/s0098-2997(03)00012-8.
Due to the cytotoxicity of 4-hydroxynonenal (HNE), and to the fact that this major product of lipid peroxidation is a rather long-living compound compared with reactive oxygen species, the capability of organisms to inactivate and eliminate HNE has received increasing attention during the last decade. Several recent in vivo studies have addressed the issue of the diffusion, kinetics, biotransformation and excretion of HNE. Part of these studies are primarily concerned with the toxicological significance of HNE biotransformation and more precisely with the metabolic pathways by which HNE is inactivated and eliminated. The other aim of in vivo metabolic study is the characterisation of end-metabolites, especially in urine, in order to develop specific and non-invasive biomarkers of lipid peroxidation. When HNE is administered intravenously or intraperitoneally, it is mainly excreted into urine and bile as conjugated metabolites, in a proportion that is dependent on the administration route. However, biliary metabolites undergo an enterohepatic cycle that limits the final excretion of faecal metabolites. Only a very low amount of metabolites is found to be bound to macromolecules. The main urinary metabolites are represented by two groups of compounds. One comes from the mercapturic acid formation from (i) 1,4 dihydroxynonene-glutathione (DHN-GSH) which originates from the conjugation of HNE with GSH by glutathione-S-transferases and the subsequent reduction of the aldehyde by a member of aldo-keto reductase superfamily; (ii) the lactone of 4-hydroxynonanoic-GSH (HNA-lactone-GSH) which originates from the conjugation of HNE followed by the oxidation of the aldehyde by aldehyde dehydrogenase; (iii) HNA-GSH which originates from the hydrolysis of the corresponding lactone. The other one is a group of metabolites issuing from the omega-hydroxylation of HNA or HNA-lactone by cytochromes P450 4A, followed eventually, in the case of omega-oxidized-HNA-lactone, by conjugation with GSH and subsequent mercapturic acid formation. Biliary metabolites are GSH or mercapturic acid conjugates of DHN, HNE and HNA. Stereochemical aspects of HNE metabolism are also discussed.
由于4-羟基壬烯醛(HNE)具有细胞毒性,且与活性氧相比,这种脂质过氧化的主要产物是一种寿命相对较长的化合物,因此在过去十年中,生物体灭活和消除HNE的能力受到了越来越多的关注。最近的几项体内研究探讨了HNE的扩散、动力学、生物转化和排泄问题。这些研究部分主要关注HNE生物转化的毒理学意义,更确切地说是关注HNE被灭活和消除的代谢途径。体内代谢研究的另一个目的是对终末代谢产物进行表征,尤其是尿液中的终末代谢产物,以便开发脂质过氧化的特异性和非侵入性生物标志物。当静脉内或腹腔内给予HNE时,它主要以结合代谢产物的形式排泄到尿液和胆汁中,其比例取决于给药途径。然而,胆汁代谢产物会经历肠肝循环,这限制了粪便代谢产物的最终排泄。只有极少量的代谢产物与大分子结合。主要的尿液代谢产物由两组化合物代表。一组来自(i)1,4-二羟基壬烯-谷胱甘肽(DHN-GSH)形成的巯基尿酸,其源于HNE与谷胱甘肽-S-转移酶结合形成的GSH以及随后醛酮还原酶超家族成员对醛的还原;(ii)4-羟基壬酸-GSH(HNA-内酯-GSH)的内酯,其源于HNE的结合,随后醛脱氢酶将醛氧化;(iii)HNA-GSH,其源于相应内酯的水解。另一组是由细胞色素P450 4A对HNA或HNA-内酯进行ω-羟基化产生的一组代谢产物,在ω-氧化-HNA-内酯的情况下,最终会与GSH结合并随后形成巯基尿酸。胆汁代谢产物是DHN、HNE和HNA的GSH或巯基尿酸结合物。还讨论了HNE代谢的立体化学方面。